Stillwaters Physical Therapy | |
865 Waterman Avenue, Stillwaters Pt, E Providence, RI 02914 | |
(401) 438-0191 | |
(401) 438-6181 |
Full Name | Stillwaters Physical Therapy |
---|---|
Type | Facility |
Speciality | Physical Therapist |
Location | 865 Waterman Avenue, E Providence, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740390699 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stillwaters Physical Therapy 865 Waterman Avenue, Stillwaters Pt, E Providence, RI 02914 Ph: (401) 438-0191 | Stillwaters Physical Therapy 865 Waterman Avenue, Stillwaters Pt, E Providence, RI 02914 Ph: (401) 438-0191 |
News Archive
With symptoms such as dryness, burning, or itching of the vagina, vulvovaginal atrophy is estimated to affect up to 98% of postmenopausal women, many of whom will fail to report symptoms to their healthcare providers or seek help.
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
Hackensack Meridian Health's academic medical centers, Hackensack University Medical Center in Hackensack, NJ and Jersey Shore University Medical Center in Neptune, NJ, are just two of only a few hospitals in the country and two of only three hospitals in New Jersey to offer an innovative new treatment that dramatically reduces the risk of stroke in patients with blocked carotid arteries, the major blood vessels that deliver blood to the brain.
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms (VMS) associated with menopause.
Combining a compound known as a gallium corrole with a protein carrier results in a targeted cancer therapy that is able to detect and eliminate tumors in mice with seemingly fewer side effects than other breast-cancer treatments, says a team of researchers from the California Institute of Technology (Caltech), the Israel Institute of Technology (Technion) and the Cedars-Sinai Medical Center.
› Verified 1 days ago
David J Boucher, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1001 Waterman Ave, E Providence, RI 02914 Phone: 401-434-1773 Fax: 401-435-0500 | |
Mrs. Cathleen Louise Rooks, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1001 Waterman Ave, E Providence, RI 02914 Phone: 401-434-1773 Fax: 401-435-0500 | |
Ms. Lauren Elizabeth Borge, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1001 Waterman Ave, E Providence, RI 02914 Phone: 401-434-1773 Fax: 401-435-0500 | |
Mrs. Paula Valente Silva, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1011 Waterman Ave, E Providence, RI 02914 Phone: 401-270-7711 |